Poseida Therapeutics, Inc. PSTX
Trading inactive
| Déclarant | Citoyenneté ou lieu d'organisation | Pouvoir de vote unique | Pouvoir de vote partagé | Pouvoir de disposition unique | Pouvoir de disposition partagé | Montant en propriété effective | Pourcentage détenu | Date d'achat |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | Delaware | 0 | 0 | 5123969 | 0 | 5123969 | 5.3 % | 22/10/2024 |
| BlackRock, Inc. | Delaware | 4716365 | 0 | 4827239 | 0 | 4827239 | 4.97 % | 07/06/2024 |
| BlackRock, Inc. | Delaware | 4930835 | 0 | 5031173 | 0 | 5031173 | 5.3 % | 31/01/2024 |
| Novartis AG | Switzerland | 0 | 5908089 | 0 | 5908089 | 5908089 | 9.6 % | 12/02/2021 |
| Novartis AG | Switzerland | 0 | 5908089 | 0 | 5908089 | 5908089 | 9.6 % | 12/02/2021 |
| Novartis Pharma AG | Switzerland | 0 | 5908089 | 0 | 5908089 | 5908089 | 9.6 % | 12/02/2021 |
| Novartis Pharma AG | Switzerland | 0 | 5908089 | 0 | 5908089 | 5908089 | 9.6 % | 12/02/2021 |
| Abigail P. Johnson | United States of America | 0 | 0 | 9273001 | 0 | 9273001 | 14.999 % | 08/02/2021 |
| FMR LLC | Delaware | 1571538 | 0 | 9273001 | 0 | 9273001 | 14.999 % | 08/02/2021 |
| FMR LLC | Delaware | 1571538 | 0 | 9273001 | 0 | 9273001 | 14.999 % | 08/02/2021 |
| Abigail P. Johnson | United States of America | 0 | 0 | 9273001 | 0 | 9273001 | 14.999 % | 08/02/2021 |
| Malin Life Sciences Holdings Limited | Ireland | 0 | 9188125 | 0 | 9188125 | 9188125 | 14.9 % | 03/02/2021 |
| Malin Corporation plc | Ireland | 0 | 9188125 | 0 | 9188125 | 9188125 | 14.9 % | 03/02/2021 |
| FMR LLC | Delaware | 1839797 | 0 | 9272382 | 0 | 9272382 | 14.999 % | 10/08/2020 |
| FMR LLC | Delaware | 1839797 | 0 | 9272382 | 0 | 9272382 | 14.999 % | 10/08/2020 |
| Abigail P. Johnson | United States of America | 0 | 0 | 9272382 | 0 | 9272382 | 14.999 % | 10/08/2020 |
| Abigail P. Johnson | United States of America | 0 | 0 | 9272382 | 0 | 9272382 | 14.999 % | 10/08/2020 |